Lumos Pharma Inc (NASDAQ:LUMO)
| 3.36 BATS BZX Real-Time Price As of Mar 28 |  0.00 / 0.00%Today’s Change | 2.95 Today|||52-Week Range 10.10 | -6.93% Year-to-Date |
Latest LUMO News | Press Releases
No recent news for Lumos Pharma Inc.
Today’s Trading
| Previous close | 3.36 |
| Today’s open | 3.36 |
| Day’s range | 3.36 - 3.36 |
| Volume | 4 |
| Average volume (3 months) | 23,844 |
| Market cap | $26.9M |
Data as of 3:13pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -1.60% |
| Earnings growth (this year) | -21.52% |
| Earnings growth (next 5 years) | +15.24% |
| Revenue growth (last year) | +562.17% |
| P/E ratio | NM |
| Price/Sales | 19.85 |
| Price/Book | 0.46 |
Competitors
| ---- | ||
| NLTXNeoleukin Therapeuti... | +0.06 | +10.41% |
| MBRXMoleculin Biotech In... | 0.00 | 0.00% |
| CASICASI Pharmaceuticals... | +0.09 | +4.88% |
Data as of 1:15pm ET, 03/29/2023
Financials
| Next reporting date | June 1, 2023 |
| EPS forecast (this quarter) | -$1.12 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$31.1M |
| Net profit margin | -2,039.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
